Market Closed

ALLO
Allogene Therapeutics
$ 0.8387
1.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Allogene Therapeutics News

Latest Allogene Therapeutics Stock News & ALLO Headlines

Allogene Therapeutics, Inc. (ALLO) Reviews Preliminary ALLO-329 Safety and Efficacy Data in Autoimmune Diseases Transcript
6 days ago | seekingalpha.com
Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease
7 days ago | globenewswire.com
Allogene Therapeutics, Inc. (ALLO) Q3 2026 Earnings Call Transcript
9 days ago | seekingalpha.com
Allogene Therapeutics Q3 Earnings Call Highlights
10 days ago | marketbeat.com
Allogene Therapeutics Reports Third Quarter 2026 Financial Results and Business Update
10 days ago | globenewswire.com
Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
18 days ago | globenewswire.com
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
21 days ago | globenewswire.com
3,187,320 Shares of Allogene Therapeutics, Inc. $ALLO Acquired by Bank of America Corp DE
2 months ago | defenseworld.net
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
2 months ago | zacks.com
Allogene Therapeutics, Inc. (ALLO) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
2 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ALLO
Allogene Therapeutics
$ 0.8387
1.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago